BlackRock Investment Management, LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 225 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$1,318,000
+13.7%
45,695
+25.4%
0.00%
+100.0%
Q3 2016$1,159,000
+1.0%
36,436
+3.0%
0.00%0.0%
Q2 2016$1,148,000
-86.0%
35,369
-88.0%
0.00%
-90.9%
Q1 2016$8,219,000
-18.2%
293,964
+4.3%
0.01%
-15.4%
Q4 2015$10,048,000
+8.4%
281,840
+0.5%
0.01%0.0%
Q3 2015$9,270,000
-22.0%
280,325
-1.2%
0.01%
-13.3%
Q2 2015$11,881,000
+65.9%
283,682
+29.1%
0.02%
+66.7%
Q1 2015$7,160,000
+4.1%
219,708
+1.4%
0.01%0.0%
Q4 2014$6,881,000
+27.2%
216,723
-0.8%
0.01%
+12.5%
Q3 2014$5,410,000
-2.9%
218,506
-11.4%
0.01%
+14.3%
Q2 2014$5,572,000
+6.1%
246,650
+14.3%
0.01%
-12.5%
Q1 2014$5,251,000
+7.7%
215,810
+10.6%
0.01%
+14.3%
Q4 2013$4,875,000
-11.3%
195,083
-2.5%
0.01%
-22.2%
Q3 2013$5,496,000
+60.7%
200,075
+6.1%
0.01%
+50.0%
Q2 2013$3,421,000188,4860.01%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
March Altus Capital Management LP 82,723$2,685,00020.75%
HWG Holdings LP 289,380$9,393,0008.72%
Baker Brothers Advisors 24,516,738$795,813,0008.34%
HARVEY CAPITAL MANAGEMENT INC 352,200$11,432,0005.73%
Belmont Global Advisors, Inc. 150,000$4,869,0004.67%
Palo Alto Investors LP 1,437,730$46,669,0003.52%
Avoro Capital Advisors LLC 329,500$10,696,0002.38%
GARRISON BRADFORD & ASSOCIATES INC 70,100$2,275,0002.23%
WEATHERBIE CAPITAL, LLC 401,642$13,037,0001.85%
ACUTA CAPITAL PARTNERS, LLC 85,999$2,792,0001.34%
View complete list of ACADIA PHARMACEUTICALS INC shareholders